Startups
UK specialist in nuclear medicine, radiotherapy and diagnostic imaging solutions. Trusted supplier to NHS trusts, oncology departments, research…
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 21, 2024 | MVision AI has won the public tender from the Republic of Ireland’s Health Service Executive (HSE) | Guideline-Based AI Segmentation MVision AI is delighted to announce that we have received our 2nd order for the Republic of Ireland from St. Luke’s Radiation Oncology Network (SLRON) HELSINKI, FINLAND, February 21, 2024 /EINPresswire.com/ -... |
| Mar 29, 2022 | Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix® | MELBOURNE, Australia and LIÈGE, Belgium, March 29, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed an exclusive agreement with Xiel Limited (Xiel) for the distribution of Telix... |
Reviews 0
FAQ about Xiel
What has the press written about Xiel?
Parsers VC has collected 3 articles mentioning Xiel, among them “MVision AI has won the public tender from the Republic of Ireland’s Health Service Executive (HSE)” (Feb 21, 2024) and “Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix®” (Mar 29, 2022).
Is Xiel still active?
Yes, Xiel is active; its latest activity on Parsers VC dates from Feb 13, 2025.